Top

Published in:

01-06-2011 | Original Research Article

Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events

A Pooled Analysis

Authors: Dr Eliot A. Brinton, Moti L. Kashyap, Anthony N. Vo, Roopal B. Thakkar, Ping Jiang, Robert J. Padley

Title: Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events
A Pooled Analysis
Authors: Dr Eliot A. Brinton
Moti L. Kashyap
Anthony N. Vo
Roopal B. Thakkar
Ping Jiang
Robert J. Padley
Publication date: 01-06-2011
Publisher: Springer International Publishing
Published in: American Journal of Cardiovascular Drugs / Issue 3/2011
Print ISSN: 1175-3277
Electronic ISSN: 1179-187X
DOI: https://doi.org/10.2165/11592560-000000000-00000